One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Toward Comprehensive Care for Long Covid
Janko Ž. Nikolich, M.D., Ph.D., and Clifford J. Rosen, M.D.
doi : 10.1056/NEJMp2304550
Vol. 388 No. 23
Approving Workplace Accommodations for Patients with Long Covid — Advice for Clinicians
Doron Dorfman, L.L.B., J.S.D., and Zackary Berger, M.D., Ph.D.
doi : 10.1056/NEJMp2302676
Over-the-Counter Hearing Aids — Using Regulatory Policy to Improve Public Health
Frank R. Lin, M.D., Ph.D., and Shelly Chadha, M.B., B.S., Ph.D.
doi : 10.1056/NEJMp2302355
Transplantation Outcomes with Donor Hearts after Circulatory Death
Jacob N. Schroder, M.D., Chetan B. Patel, M.D., Adam D. DeVore, M.D., Benjamin S. Bryner, M.D., Sarah Casalinova, B.S., Ashish Shah, M.D., Jason W. Smith, M.D., Amy G. Fiedler, M.D., Mani Daneshmand, M.D., Scott Silvestry, M.D., Arnar Geirsson, M.D., Victor Pretorius, M.B., Ch.B., David L. Joyce, M.D., John Y. Um, M.D., Fardad Esmailian, M.D., Koji Takeda, M.D., Karol Mudy, M.D., Yasuhiro Shudo, M.D., Ph.D., Christopher T. Salerno, M.D., Si M. Pham, M.D., Daniel J. Goldstein, M.D., Jonathan Philpott, M.D., John Dunning, M.D., Lucian Lozonschi, M.D., Gregory S. Couper, M.D., Hari Reddy Mallidi, M.D., Michael M. Givertz, M.D., Duc Thinh Pham, M.D., Andrew W. Shaffer, M.D., Masashi Kai, M.D., Mohammed A. Quader, M.D., Tarek Absi, M.D., Tamer S. Attia, M.D., Ph.D., Bassam Shukrallah, M.D., Ben C. Sun, M.D., Maryjane Farr, M.D., Mandeep R. Mehra, M.D., Joren C. Madsen, M.D., D.Phil., Carmelo A. Milano, M.D., and David A. D’Alessandro, M.D.
doi : 10.1056/NEJMoa2212438
Data showing the efficacy and safety of the transplantation of hearts obtained from donors after circulatory death as compared with hearts obtained from donors after brain death are limited.
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
David Simmons, M.D., Jincy Immanuel, Ph.D., William M. Hague, M.D., Helena Teede, Ph.D., Christopher J. Nolan, Ph.D., Michael J. Peek, Ph.D., Jeff R. Flack, M.Med., Mark McLean, Ph.D., Vincent Wong, Ph.D., Emily Hibbert, M.Clin.Ed., Alexandra Kautzky-Willer, M.D., Jürgen Harreiter, Ph.D.,
doi : 10.1056/NEJMoa2214956
Whether treatment of gestational diabetes before 20 weeks’ gestation improves maternal and infant health is unclear.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R. Mirza, M.D., Dana M. Chase, M.D., Brian M. Slomovitz, M.D., René dePont Christensen, Ph.D., Zoltán Novák, Ph.D., Destin Black, M.D., Lucy Gilbert, M.D., Sudarshan Sharma, M.D., Giorgio Valabrega, M.D., Lisa M. Landrum, M.D., Ph.D., Lars C. Hanker, M.D., Ashley Stuckey, M.D., Ingrid Boere, M.D., Ph.D., Michael A. Gold, M.D., Annika Auranen, M.D., Bhavana Pothuri, M.D., David Cibula, M.D., Carolyn McCourt, M.D., Francesco Raspagliesi, M.D., Mark S. Shahin, M.D., Sarah E. Gill, M.D., Bradley J. Monk, M.D., Joseph Buscema, M.D., Thomas J. Herzog, M.D., Larry J. Copeland, M.D., Min Tian, Ph.D., Zangdong He, Ph.D., Shadi Stevens, M.D., Eleftherios Zografos, M.D., Robert L. Coleman, M.D., and Matthew A. Powell, M.D. for the RUBY Investigators*
doi : 10.1056/NEJMoa2216334
Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in the treatment of endometrial cancer.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, M.D., Michael W. Sill, Ph.D., Lindsey Beffa, M.D., Richard G. Moore, M.D., Joanie M. Hope, M.D., Fernanda B. Musa, M.D., Robert Mannel, M.D., Mark S. Shahin, M.D., Guilherme H. Cantuaria, M.D., Eugenia Girda, M.D., Cara Mathews, M.D., Juraj Kavecansky, M.D., Charles A. Leath, III, M.D., M.S.P.H., Lilian T. Gien, M.D., Emily M. Hinchcliff, M.D., M.P.H., Shashikant B. Lele, M.D., Lisa M. Landrum, M.D., Floor Backes, M.D., Roisin E. O’Cearbhaill, M.D., Tareq Al Baghdadi, M.D., Emily K. Hill, M.D., Premal H. Thaker, M.D., Veena S. John, M.D., Stephen Welch, M.D., Amanda N. Fader, M.D., Matthew A. Powell, M.D., and Carol Aghajanian, M.D.
doi : 10.1056/NEJMoa2302312
Standard first-line chemotherapy for endometrial cancer is paclitaxel plus carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear.
Posterior Reversible Encephalopathy Syndrome
Romergryko G. Geocadin, M.D.
doi : 10.1056/NEJMra2114482
Idiopathic Pulmonary Hemosiderosis
Kazuhiro Uda, M.D., and Masato Yashiro, M.D., Ph.D.
doi : 10.1056/NEJMicm2214160
Posterior Reversible Encephalopathy Syndrome
Saifudheen Kondanath, M.D., and Muhammad Ariwala, M.D.
doi : 10.1056/NEJMicm2213584
Case 17-2023: A 58-Year-Old Woman with Fatigue, Abdominal Bloating, and Eosinophilia
Natasha S. Hochberg, M.D., M.P.H., Vincent V. Dinculescu, M.D., and Thomas B. Nutman, M.D.
doi : 10.1056/NEJMcpc2201248
Safely Increasing Heart Transplantation with Donation after Cardiac Death
Nancy K. Sweitzer, M.D., Ph.D.
doi : 10.1056/NEJMe2303928
Early versus Second-Trimester Screening and Treatment for Diabetes in Pregnancy
Michael F. Greene, M.D.
doi : 10.1056/NEJMe2304543
Management of Possible Multiple Sclerosis
Clement D. Lee, M.D., Steven L. Galetta, M.D., and Ruth Dobson, Ph.D., F.R.C.P.
doi : 10.1056/NEJMclde2300812
Antibody-Associated Reversal of ATTR Amyloidosis–Related Cardiomyopathy
doi : 10.1056/NEJMc2304584
Transcatheter Arterialization of Veins in Chronic Limb-Threatening Ischemia
doi : 10.1056/NEJMc2304972
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
doi : 10.1056/NEJMx230003
